[REVISION HISTORY]

Wandercraft medical exoskeleton market expansion

Updated 1 time since CLSTR started tracking revisions of this situation.

What changed

2026-10-03 19:22 UTC → 2026-10-06 07:16 UTC · added ~~removed~~

French company Wandercraft expanded its presence in the medical exoskeleton market through regulatory milestones and strategic acquisition. In late September 2026, the U.S. Food and Drug Administration (FDA) cleared the commercial launch of Eve, a self-balancing robotic exoskeleton designed for adults with spinal cord injuries. The device allows users to stand and walk without crutches or walkers, utilizing twelve motors and integrated sensors to maintain stability. The technology incorporates advanced robotics and artificial intelligence to maintain stability while allowing for hands-free movement, which enables users to perform daily tasks, such as handling objects or preparing food, independently. Following this launch, Wandercraft completed the acquisition of Ekso Bionics. This merger combined Wandercraft’s robotics expertise with Ekso Bionics’ established U.S. clinical infrastructure, creating the world’s largest manufacturer of medical exoskeletons. The unified company maintains a portfolio of four specialized systems for clinical rehabilitation and individual mobility, serving over 700 research and rehabilitation centers globally.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.